文献速递糖尿病

跨越2型糖尿病变异到功能的鸿沟:进展与挑战

Bridging the variant-to-function gap in type 2 diabetes: advances and challenges.
PubMed 文献 · Diabetologia · 2025-11-22

本综述总结了精细定位、染色质分析、单细胞多组学、可扩展CRISPR扰动策略及机器学习等变异到功能(V2F)策略如何将非编码变异链接至效应基因、组织与分子机制,并列举了TCF7L2、SLC16A11、PNPLA3及GLUT4 trafficking等示例。

要点

  • V2F策略可连接非编码变异与效应基因及组织。
  • β细胞中TCF7L2、肝细胞中SLC16A11与PNPLA3、脂肪与肌肉中GLUT4 trafficking为已解析示例。
  • 整合多组学与CRISPR扰动有望推动精准医学。

核心结论

  • V2F策略的进展正接近弥合遗传关联与机制之间的鸿沟,为2型糖尿病精准医学奠定基础。

研究设计与样本

  • 本综述综合了精细定位、染色质 profiling、单细胞多组学、可扩展CRISPR扰动策略及机器学习工具等V2F策略的进展。

主要发现

  • 全基因组关联研究已识别超过1200个与2型糖尿病相关的位点,但仅解释了 modest proportion 的疾病遗传力,且多数风险变异位于非编码区。
  • V2F策略已在关键2型糖尿病组织中解析示例,包括TCF7L2在胰腺β细胞发育中的作用、SLC16A11与PNPLA3在肝细胞脂质代谢中的作用以及脂肪细胞和肌肉中的GLUT4 trafficking通路。
  • 综述提供了经遗传锚定且实验支持的2型糖尿病V2F发现总结表,并描述了应对疾病异质性与情境依赖性的新兴工具与框架。

局限性

  • 仅 modest proportion 的疾病遗传力已被解释,且多数风险变异位于非编码区,增加了生物学解释的复杂性。
  • 疾病异质性与情境依赖性构成挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Type 2 diabetes is a polygenic, heterogeneous disease affecting over 530 million individuals worldwide, a number projected to rise to 1.3 billion by 2050. Genome-wide association studies have identified over 1200 loci associated with type 2 diabetes, yet only a modest proportion of disease heritability has been explained, and most risk variants lie in non-coding regions, complicating biological interpretation. This review synthesises how recent advances in variant-to-function (V2F) strategies, including fine-mapping, chromatin profiling, single-cell multi-omics, scalable CRISPR-based perturbation strategies and machine learning tools, have begun to link non-coding variants to effector genes, tissues and molecular mechanisms. We highlight examples of V2F resolution across key type 2 diabetes tissues, including the roles of TCF7L2 in pancreatic beta cell development, SLC16A11 and PNPLA3 in hepatocyte lipid metabolism, and GLUT4 trafficking pathways in adipocytes and muscle. We provide a summary table of genetically anchored, experimentally supported V2F discoveries in type 2 diabetes, and describe emerging tools and frameworks to address disease heterogeneity and context dependence. Together, these developments are on the cusp of closing the genetic association and mechanism gap while laying the foundation for future precision medicine approaches in type 2 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Maynard AG, Bhardwaj R, Jones TR, et al. Bridging the variant-to-function gap in type 2 diabetes: advances and challenges. Diabetologia. 2025. PMID: 41273414. doi:10.1007/s00125-025-06600-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。